NCT04756401 Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04754945 Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04752852 Use of Prophylactic Steroids in the Prevention of Post-thyroidectomy Hypocalcaemia and Voice Dysfunction Status COMPLETED Phase NA
NCT04752163 DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT04751877 Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years). Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04747912 Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) Status SUSPENDED Phase PHASE2
NCT04747080 The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT04746430 COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study Status TERMINATED Phase PHASE4
NCT04743661 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04737980 Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair Status COMPLETED Phase PHASE4
NCT04729114 A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer Status RECRUITING Phase PHASE1
NCT04714112 Low-dose Intravenous Dexamethasone at Different Times as Adjunvants for Brachial Plexus Blocks Status COMPLETED Phase PHASE4
NCT04707534 Comparing the Effects of Different Doses of Dexamethasone to Treat Inpatient COVID-19 Status COMPLETED Phase PHASE4
NCT04700176 A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma Status TERMINATED Phase PHASE2
NCT04694105 Peri-neural Dexmedetomidine Versus Dexamethasone for Supraaclavicular Block Adjuvant to Bupivacaine Supraclavicular Brachial Plexus Block Status COMPLETED Phase NA
NCT04690647 The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. Status COMPLETED Phase NA
NCT04681105 Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies Status COMPLETED Phase PHASE1
NCT04667663 CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. Status ACTIVE_NOT_RECRUITING Phase PHASE1